Gilead Sciences Ltd. Drug Offers Hope Against Tough-to-Treat Hypertension, State University of New York at Buffalo Study

Doctor’s Guide -- NEW YORK -- September 13, 2009 -- Darusentan provides additional reduction in blood pressure in patients who have not attained their treatment goals with 3 or more antihypertensive drugs, according to a study published online first and in an upcoming edition of The Lancet.

MORE ON THIS TOPIC